Integral Health Asset Management »

Tg Therapeutics shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.5M 150k 30.10
2023-06-30 $6.2M 250k 24.84
2022-12-31 $1.8M 150k 11.83

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
ClearBridge Advisors
Soleus Capital Management
Geode Capital Management
Susquehanna International
Jane Street
Citadel Advisors
Pictet Asset Management Holding SA
Hood River Capital Management
Goldman Sachs Group
Northern Trust
Morgan Stanley
Charles Schwab Investment Management

View all funds holding Tg Therapeutics